Shawn O'Brien
Vorstandsvorsitzender bei MAYNE PHARMA GROUP LIMITED
Vermögen: 167 646 $ am 30.04.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Joan Chypyha | F | 57 |
Alto Pharmaceuticals Ltd.
 Alto Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Alto Pharmaceuticals Ltd. Develops and commercialize products for maintaining a healthy lifestyle and improving quality of life. The firm’s area of interest includes dermatology and skin care, as well as post surgical support. The company was founded by Joan Chypyha in 2008 and is headquartered in Oakridges, Canada. | 16 Jahre |
| Frank Condella | M | 70 | 6 Jahre | |
| Norman Evans | M | 70 |
Alto Pharmaceuticals Ltd.
Alto Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Alto Pharmaceuticals Ltd. Develops and commercialize products for maintaining a healthy lifestyle and improving quality of life. The firm’s area of interest includes dermatology and skin care, as well as post surgical support. The company was founded by Joan Chypyha in 2008 and is headquartered in Oakridges, Canada. | 10 Jahre |
| Bruce Robinson | M | 67 | 10 Jahre | |
| Harold Wolkin | M | 72 | 8 Jahre | |
| Patrick Blake | M | 59 | 6 Jahre | |
| Robert Dickey | M | 68 |
SFA Therapeutics, Inc.
 SFA Therapeutics, Inc. Packaged SoftwareTechnology Services SFA Therapeutics, Inc. is a clinical-stage biotech company based on breakthrough research of the human microbiome licensed from Temple University. SFA Therapeutics is located in Jenkintown, PA. Ira Spector has been the CEO of the company since 2017. The company is developing a platform of safer therapeutics focused on the treatment of inflammatory diseases, targeting NF-kB and RAS. SFA has identified six small molecule drug candidates from this platform, including its lead asset, SFA-002, which has shown promising phase 1a results and is currently being investigated in a phase 1b study for psoriasis. The company's research program is focused on the intersection of chronic inflammation and cancer. | 3 Jahre |
| John H. Eldridge | M | - |
Profectus BioSciences, Inc.
 Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Profectus BioSciences, Inc. engages in the design and development of preventive and therapeutic vaccines. It develops novel vaccines for the prevention and treatment of infectious diseases and related cancers. The company’s vaccines are based on its proprietary VesiculoVax and GeneVax vaccine delivery platforms. The company was founded by Robert Charles Gallo, William A. Blattner, and Robert R. Redfield in 2003 and is headquartered in Baltimore, MD. | 16 Jahre |
| Laura Loftus | F | - | 4 Jahre | |
| Gerard G. Nahum | M | - | - | |
| Keith Moore | M | - | 9 Jahre | |
| Ann Custin | F | 64 | 2 Jahre | |
| Aaron Gray | M | - | 2 Jahre | |
| Richard Moldin | M | - | - | |
| Kimberly Parker | F | - | - | |
| David Petrie | M | - | 2 Jahre | |
| Erinn Nathaniel | F | - | - | |
| James Kirwin | M | - |
SFA Therapeutics, Inc.
SFA Therapeutics, Inc. Packaged SoftwareTechnology Services SFA Therapeutics, Inc. is a clinical-stage biotech company based on breakthrough research of the human microbiome licensed from Temple University. SFA Therapeutics is located in Jenkintown, PA. Ira Spector has been the CEO of the company since 2017. The company is developing a platform of safer therapeutics focused on the treatment of inflammatory diseases, targeting NF-kB and RAS. SFA has identified six small molecule drug candidates from this platform, including its lead asset, SFA-002, which has shown promising phase 1a results and is currently being investigated in a phase 1b study for psoriasis. The company's research program is focused on the intersection of chronic inflammation and cancer. | 4 Jahre |
| Hemanshu N. Pandya | M | 52 | 3 Jahre | |
| Anne Lockwood | F | - | 1 Jahre | |
| Marc Tremblay | M | - |
Profectus BioSciences, Inc.
Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Profectus BioSciences, Inc. engages in the design and development of preventive and therapeutic vaccines. It develops novel vaccines for the prevention and treatment of infectious diseases and related cancers. The company’s vaccines are based on its proprietary VesiculoVax and GeneVax vaccine delivery platforms. The company was founded by Robert Charles Gallo, William A. Blattner, and Robert R. Redfield in 2003 and is headquartered in Baltimore, MD. | 16 Jahre |
| Ira Spector | M | - |
SFA Therapeutics, Inc.
SFA Therapeutics, Inc. Packaged SoftwareTechnology Services SFA Therapeutics, Inc. is a clinical-stage biotech company based on breakthrough research of the human microbiome licensed from Temple University. SFA Therapeutics is located in Jenkintown, PA. Ira Spector has been the CEO of the company since 2017. The company is developing a platform of safer therapeutics focused on the treatment of inflammatory diseases, targeting NF-kB and RAS. SFA has identified six small molecule drug candidates from this platform, including its lead asset, SFA-002, which has shown promising phase 1a results and is currently being investigated in a phase 1b study for psoriasis. The company's research program is focused on the intersection of chronic inflammation and cancer. | 7 Jahre |
| Kathryn MacFarlane | M | 58 | 2 Jahre | |
| Alan M. Gordon | M | - |
Profectus BioSciences, Inc.
Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Profectus BioSciences, Inc. engages in the design and development of preventive and therapeutic vaccines. It develops novel vaccines for the prevention and treatment of infectious diseases and related cancers. The company’s vaccines are based on its proprietary VesiculoVax and GeneVax vaccine delivery platforms. The company was founded by Robert Charles Gallo, William A. Blattner, and Robert R. Redfield in 2003 and is headquartered in Baltimore, MD. | 14 Jahre |
| Frank Casty | M | - | - | |
| David Karl Clarke | M | 69 |
Profectus BioSciences, Inc.
Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Profectus BioSciences, Inc. engages in the design and development of preventive and therapeutic vaccines. It develops novel vaccines for the prevention and treatment of infectious diseases and related cancers. The company’s vaccines are based on its proprietary VesiculoVax and GeneVax vaccine delivery platforms. The company was founded by Robert Charles Gallo, William A. Blattner, and Robert R. Redfield in 2003 and is headquartered in Baltimore, MD. | 16 Jahre |
| Michael A. Egan | M | - |
Profectus BioSciences, Inc.
Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Profectus BioSciences, Inc. engages in the design and development of preventive and therapeutic vaccines. It develops novel vaccines for the prevention and treatment of infectious diseases and related cancers. The company’s vaccines are based on its proprietary VesiculoVax and GeneVax vaccine delivery platforms. The company was founded by Robert Charles Gallo, William A. Blattner, and Robert R. Redfield in 2003 and is headquartered in Baltimore, MD. | 16 Jahre |
| Brant Schofield | M | - | 6 Jahre | |
| Geert Cauwenbergh | M | 70 |
Alto Pharmaceuticals Ltd.
Alto Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Alto Pharmaceuticals Ltd. Develops and commercialize products for maintaining a healthy lifestyle and improving quality of life. The firm’s area of interest includes dermatology and skin care, as well as post surgical support. The company was founded by Joan Chypyha in 2008 and is headquartered in Oakridges, Canada. | - |
| Craig Haskins | M | - | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Larry Andrews | M | 71 | 10 Jahre | |
| Patrick J. Gavin | M | 60 |
Crozer-Keystone Health System
 Crozer-Keystone Health System Medical/Nursing ServicesHealth Services Crozer-Keystone Health System provides full spectrum of wellness, prevention, acute care, rehabilitation and restorative care to the community. It services includes a Level 2 trauma center; a regional burn center; three regional cancer centers affiliated with Fox Chase Cancer Center; a fertility center; sleep-disorders centers; wound care centers with hyperbaric medicine; comprehensive maternity services, including intensive care nurseries and maternal fetal medicine; a kidney transplant center; advanced heart care services, including open heart surgery; orthopedic services, sports medicine and physical therapy and rehabilitation services; senior health services; a bariatric surgery program; medical imaging services; and a comprehensive physician network of primary-care and specialty practices. The company was founded in 1990 and is headquartered in Springfield, PA. | 6 Jahre |
| Stephen Lemieux | M | 48 | 3 Jahre | |
| Gerald P. McDole | M | 84 | 12 Jahre | |
| Robert Tessarolo | M | 56 | 2 Jahre | |
| Lisa Pendlebury | F | 49 | - | |
| Scott Richards | M | 60 | 10 Jahre | |
| William D. Claypool | M | 72 | 7 Jahre | |
| Christian Godin | M | - | 7 Jahre | |
| Mark A. Beaudet | M | - | 3 Jahre | |
| Louise Blythe | F | - | 1 Jahre | |
| Brian Rosenberger | M | 55 | 2 Jahre | |
| Gina Ford | M | - |
Solstice Neurosciences, Inc.
 Solstice Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Solstice Neurosciences, Inc. was a specialty biopharmaceutical company focused on the development, manufacturing, sales and marketing of specialty biopharmaceutical products. The company was founded in 2004 and is headquartered in Malvern, PA. | 2 Jahre |
| Stefan J. Cross | M | 51 | 11 Jahre | |
| Andrew Herdman | M | - | - | |
| Charles F. Jenkins | M | - | - | |
| Romano DiToro | M | - |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | - |
| Ralph Bohrer | M | - | 1 Jahre | |
| Lynne Bulger | F | - | 2 Jahre | |
| Thomas G. Paese | M | - |
Profectus BioSciences, Inc.
Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Profectus BioSciences, Inc. engages in the design and development of preventive and therapeutic vaccines. It develops novel vaccines for the prevention and treatment of infectious diseases and related cancers. The company’s vaccines are based on its proprietary VesiculoVax and GeneVax vaccine delivery platforms. The company was founded by Robert Charles Gallo, William A. Blattner, and Robert R. Redfield in 2003 and is headquartered in Baltimore, MD. | - |
| Rosemary Crane | F | 64 | - | |
| Renee Tannenbaum | M | 72 | - | |
| Carolyn Myers | M | 66 | 2 Jahre | |
| Joseph Pecora | M | - | - | |
| Eric Siegel | M | 60 |
Solstice Neurosciences, Inc.
Solstice Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Solstice Neurosciences, Inc. was a specialty biopharmaceutical company focused on the development, manufacturing, sales and marketing of specialty biopharmaceutical products. The company was founded in 2004 and is headquartered in Malvern, PA. | 2 Jahre |
| Kerry Clem | M | 54 |
Solstice Neurosciences, Inc.
Solstice Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Solstice Neurosciences, Inc. was a specialty biopharmaceutical company focused on the development, manufacturing, sales and marketing of specialty biopharmaceutical products. The company was founded in 2004 and is headquartered in Malvern, PA. | 3 Jahre |
| Gregory Mayes | M | 55 |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | 3 Jahre |
| Joseph F. Berardino | M | 73 |
Profectus BioSciences, Inc.
Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Profectus BioSciences, Inc. engages in the design and development of preventive and therapeutic vaccines. It develops novel vaccines for the prevention and treatment of infectious diseases and related cancers. The company’s vaccines are based on its proprietary VesiculoVax and GeneVax vaccine delivery platforms. The company was founded by Robert Charles Gallo, William A. Blattner, and Robert R. Redfield in 2003 and is headquartered in Baltimore, MD. | 4 Jahre |
| Randall C. Mastrangelo | M | - |
Solstice Neurosciences, Inc.
Solstice Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Solstice Neurosciences, Inc. was a specialty biopharmaceutical company focused on the development, manufacturing, sales and marketing of specialty biopharmaceutical products. The company was founded in 2004 and is headquartered in Malvern, PA. | - |
| Mike A. Royal | M | 70 |
Solstice Neurosciences, Inc.
Solstice Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Solstice Neurosciences, Inc. was a specialty biopharmaceutical company focused on the development, manufacturing, sales and marketing of specialty biopharmaceutical products. The company was founded in 2004 and is headquartered in Malvern, PA. | 2 Jahre |
| Tuan Elstrom | M | - | 2 Jahre | |
| David P. Nicoli | M | - |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | - |
| Michael Brooks | M | 46 | 5 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Australien | 23 | 36,51% |
| Kanada | 21 | 33,33% |
| Vereinigte Staaten | 19 | 30,16% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Shawn O'Brien
- Persönliches Netzwerk
